| Thomas E Dobbs, MD | |
|
1440 Jefferson St, Laurel, MS 39440-4243 | |
| (601) 428-0577 | |
| (601) 426-9854 |
| Full Name | Thomas E Dobbs |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 1440 Jefferson St, Laurel, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770597882 | NPI | - | NPPES |
| 7248277 | Other | AETNA | |
| 00124354 | Medicaid | MS | |
| 1954471 | Other | UNITED HEALTH CARE | |
| H'BURG FHC-1148992 | Other | MS | WINDSOR HEALTH GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 17250 (Mississippi) | Primary |
| Entity Name | Ms State Department Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053489260 PECOS PAC ID: 0244129245 Enrollment ID: O20040315000937 |
News Archive
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.
The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine.
Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
› Verified 4 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.
The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine.
Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
› Verified 4 days ago
| Entity Name | South Central Clinics, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801226287 PECOS PAC ID: 4385876655 Enrollment ID: O20140515000834 |
News Archive
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.
The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine.
Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas E Dobbs, MD 602 Adeline St, Hattiesburg, MS 39401-3842 Ph: (601) 544-6766 | Thomas E Dobbs, MD 1440 Jefferson St, Laurel, MS 39440-4243 Ph: (601) 428-0577 |
News Archive
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.
The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine.
Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
› Verified 4 days ago
Bassam K Mechleb, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 404 S 13th Ave, Laurel, MS 39440 Phone: 601-425-5544 Fax: 601-425-5525 | |
John M. Wallace, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-9479 | |
Dr. Hamit Kumar, M.B.B.S Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-2863 | |
Carolyn Cegielski, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-9479 | |
Willus Mark Horne, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-9479 | |
Joel Thomas Shores, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-9479 | |
David L Harrison, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1203 Jefferson St, Laurel, MS 39440 Phone: 601-649-2863 Fax: 601-649-9479 |